Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperpyrexia: an update for the otolaryngologist

J A Schvaneveldt, J A Stankiewicz

    The Laryngoscope
    |June 1, 1981
    PubMed
    Summary

    Malignant hyperpyrexia (MH), a dangerous syndrome, can now be managed with dantrolene sodium. This treatment offers hope for significantly reducing MH

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Frameless stereotactic localization in cranial base surgery.

    Skull base surgery·2006
    Same author

    Against all odds: an interesting foreign body problem and solution.

    Archives of otolaryngology--head & neck surgery·2001
    Same author

    Directed functional endoscopic sinus surgery and headaches.

    Archives of otolaryngology--head & neck surgery·2000
    Same author

    Two faces of orbital hematoma in intranasal (endoscopic) sinus surgery.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1999
    Same author

    Endoscopic transsphenoidal biopsy of the sphenoid and clival mass.

    American journal of rhinology·1999
    Same author

    Juvenile aggressive ossifying fibroma presenting as an ethmoid sinus mucocele.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1998

    Area of Science:

    • Anesthesiology
    • Pharmacology
    • Medical Genetics

    Background:

    • Malignant hyperpyrexia (MH) is a life-threatening pharmacogenetic disorder.
    • MH presents a significant mortality risk (60%) when triggered by anesthetic agents.
    • Current management strategies for MH are limited.

    Purpose of the Study:

    • To review recent clinical and laboratory studies on Malignant hyperpyrexia.
    • To establish the pathophysiology of MH.
    • To outline the pharmacology of dantrolene sodium for MH treatment.

    Main Methods:

    • Review of recent clinical studies.
    • Analysis of laboratory research findings.
    • Examination of pharmacological data for dantrolene sodium.

    Main Results:

    • Dantrolene sodium has emerged as a key agent for MH management.
    • The FDA has approved intravenous Dantrium for MH treatment.
    • Intravenous and oral dantrolene show promise in reducing MH mortality.

    Conclusions:

    • Dantrolene sodium represents a significant advancement in managing Malignant hyperpyrexia.
    • The use of dantrolene sodium is supported by theoretical and experimental evidence.
    • Further research and clinical application of dantrolene sodium are expected to improve patient outcomes in MH.

    Related Experiment Videos